-
Mozavaptan (INN) is a
vasopressin receptor antagonist marketed by Ot****. In ****an, it was
approved in
October 2006 for
hyponatremia (low
blood sodium...
-
receptor antagonists and
include conivaptan, tolvaptan, demeclocycline, and
mozavaptan (OPC-31260), as well as lithium.
Conivaptan hydrochloride and tolvaptan...
-
moxidectin (INN)
moxifloxacin (INN)
moxilubant (INN)
moxipraquine (INN)
moxiraprine (INN)
moxisylyte (INN)
moxnidazole (INN)
moxonidine (INN)
mozavaptan (INN)...
-
Vasotocin (argiprestocin) Antagonists:
Conivaptan JNJ-17079166
Lixivaptan Mozavaptan RWJ-351647
Satavaptan Tolvaptan YM-471 YM-35471
Unsorted Antagonists:...
-
Vasotocin (argiprestocin) Antagonists:
Conivaptan JNJ-17079166
Lixivaptan Mozavaptan RWJ-351647
Satavaptan Tolvaptan YM-471 YM-35471
Unsorted Antagonists:...
-
Vasotocin (argiprestocin) Antagonists:
Conivaptan JNJ-17079166
Lixivaptan Mozavaptan RWJ-351647
Satavaptan Tolvaptan YM-471 YM-35471
Unsorted Antagonists:...
-
Vasotocin (argiprestocin) Antagonists:
Conivaptan JNJ-17079166
Lixivaptan Mozavaptan RWJ-351647
Satavaptan Tolvaptan YM-471 YM-35471
Unsorted Antagonists:...
-
selective for the V2
receptor include:
Tolvaptan (FDA-approved)
Lixivaptan Mozavaptan Satavaptan Their main uses are in hyponatremia, such as that
caused by...
-
include the new
class of "vaptan drugs" such as conivaptan, tolvaptan,
mozavaptan, lixivaptan,
satavaptan etc.
Holmes CL,
Landry DW,
Granton JT (December...
-
Relcovaptan V1B
selective (V3RA)
Nelivaptan V2
selective (V2RA)
Lixivaptan Mozavaptan Satavaptan Tolvaptan Somatostatin is a
competitive inhibitor. Demeclocycline...
